These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24460250)

  • 1. How to establish acute myeloid leukemia xenograft models using immunodeficient mice.
    Shan WL; Ma XL
    Asian Pac J Cancer Prev; 2013; 14(12):7057-63. PubMed ID: 24460250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models of acute myelogenous leukaemia - development, application and future perspectives.
    McCormack E; Bruserud O; Gjertsen BT
    Leukemia; 2005 May; 19(5):687-706. PubMed ID: 15759039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imaging.
    Vick B; Rothenberg M; Sandhöfer N; Carlet M; Finkenzeller C; Krupka C; Grunert M; Trumpp A; Corbacioglu S; Ebinger M; André MC; Hiddemann W; Schneider S; Subklewe M; Metzeler KH; Spiekermann K; Jeremias I
    PLoS One; 2015; 10(3):e0120925. PubMed ID: 25793878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A robust xenotransplantation model for acute myeloid leukemia.
    Sanchez PV; Perry RL; Sarry JE; Perl AE; Murphy K; Swider CR; Bagg A; Choi JK; Biegel JA; Danet-Desnoyers G; Carroll M
    Leukemia; 2009 Nov; 23(11):2109-17. PubMed ID: 19626050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia.
    Saland E; Boutzen H; Castellano R; Pouyet L; Griessinger E; Larrue C; de Toni F; Scotland S; David M; Danet-Desnoyers G; Vergez F; Barreira Y; Collette Y; Récher C; Sarry JE
    Blood Cancer J; 2015 Mar; 5(3):e297. PubMed ID: 25794133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanized model to study leukemic stem cells.
    Bonnet D
    Methods Mol Biol; 2009; 538():247-62. PubMed ID: 19277589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia.
    Her Z; Yong KSM; Paramasivam K; Tan WWS; Chan XY; Tan SY; Liu M; Fan Y; Linn YC; Hui KM; Surana U; Chen Q
    J Hematol Oncol; 2017 Oct; 10(1):162. PubMed ID: 28985760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg-/- mice.
    Zorzoli A; Di Carlo E; Cocco C; Ognio E; Ribatti D; Ferretti E; Dufour C; Locatelli F; Montagna D; Airoldi I
    Clin Cancer Res; 2012 Mar; 18(6):1630-40. PubMed ID: 22383738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenograft Models of Primary Acute Myeloid Leukemia for the Development of Imaging Strategies and Evaluation of Novel Targeted Therapies.
    Gelebart P; Popa M; McCormack E
    Curr Pharm Biotechnol; 2016; 17(1):42-51. PubMed ID: 26278528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
    Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
    Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
    Carretta M; de Boer B; Jaques J; Antonelli A; Horton SJ; Yuan H; de Bruijn JD; Groen RWJ; Vellenga E; Schuringa JJ
    Exp Hematol; 2017 Jul; 51():36-46. PubMed ID: 28456746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction and Therapeutic Targeting of Human NPM1c
    Kaur M; Drake AC; Hu G; Rudnick S; Chen Q; Phennicie R; Attar R; Nemeth J; Gaudet F; Chen J
    J Immunol; 2019 Mar; 202(6):1885-1894. PubMed ID: 30710044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
    Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
    Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from models of murine erythroleukemia to acute myeloid leukemia (AML): proof-of-principle of co-operativity in AML.
    Moreau-Gachelin F
    Haematologica; 2006 Dec; 91(12):1644-52. PubMed ID: 17145601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo.
    Sergeeva A; He H; Ruisaard K; St John L; Alatrash G; Clise-Dwyer K; Li D; Patenia R; Hong R; Sukhumalchandra P; You MJ; Gagea M; Ma Q; Molldrem JJ
    Leukemia; 2016 Jul; 30(7):1475-84. PubMed ID: 27055866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
    Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
    J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient RNA Interference of Primary Leukemic Cells for Loss-of-Function Studies in Xenograft Mouse Models.
    Nicolis di Robilant B; Noviello M
    Methods Mol Biol; 2016; 1393():113-26. PubMed ID: 27033221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice.
    Paczulla AM; Dirnhofer S; Konantz M; Medinger M; Salih HR; Rothfelder K; Tsakiris DA; Passweg JR; Lundberg P; Lengerke C
    Haematologica; 2017 May; 102(5):854-864. PubMed ID: 28183848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine models of human acute myeloid leukemia.
    Fortier JM; Graubert TA
    Cancer Treat Res; 2010; 145():183-96. PubMed ID: 20306252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
    Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
    Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.